The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study

Mark D. Tyson; Alan Bryce

doi:10.1016/j.eururo.2016.08.017

The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study

Mark D. Tyson, Alan Bryce

Hematology/Oncology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	543-544
Number of pages	2
Journal	European urology
Volume	71
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2016.08.017
State	Published - Apr 1 2017

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2016.08.017

Cite this

@article{426cc387046e42e4ae1b822468687ac0,

title = "The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study",

author = "Tyson, {Mark D.} and Alan Bryce",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.eururo.2016.08.017",

language = "English (US)",

volume = "71",

pages = "543--544",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes

T2 - Results from the TERRAIN Study

AU - Tyson, Mark D.

AU - Bryce, Alan

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=84996848298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996848298&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2016.08.017

DO - 10.1016/j.eururo.2016.08.017

M3 - Editorial

C2 - 27544580

AN - SCOPUS:84996848298

SN - 0302-2838

VL - 71

SP - 543

EP - 544

JO - European urology

JF - European urology

IS - 4

ER -

The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this